» Articles » PMID: 16236562

Determination of Schizandrin in Rat Plasma by High-performance Liquid Chromatography-mass Spectrometry and Its Application in Rat Pharmacokinetic Studies

Overview
Publisher Elsevier
Date 2005 Oct 21
PMID 16236562
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

A sensitive liquid chromatography-mass spectrometric (LC/MS) method for the quantification of schizandrin in rat plasma was developed and validated after solid-phase extraction (SPE). Chromatographic separation was achieved on a reversed-phase Shimadzu C(18) column with the mobile phase of acetonitrile-sodium acetate (10 micromol/L) and step gradient elution resulted in a total run time of about 11.7 min. The analytes were detected using an electrospray positive ionization mass spectrometry in the selected ion monitoring (SIM) mode. A good linear relationship was obtained in the concentration range studied (0.005-2.000 microg/mL) (r=0.9999). Lower limit of quantification (LLOQ) was 5 ng/mL and the lower limit of detection (LLOD) was 2 ng/mL using 100 microL plasma sample. Average recoveries ranged from 75.85 to 88.51% in plasma at the concentrations of 0.005, 0.100 and 1.000 microg/mL. Intra- and inter-day relative standard deviations were 5.95-12.93% and 3.87-14.53%, respectively. This method was successfully applied for the pharmacokinetic studies in rats.

Citing Articles

Schisandrin protects against ulcerative colitis by inhibiting the SGK1/NLRP3 signaling pathway and reshaping gut microbiota in mice.

Wang X, Shen C, Wang X, Tang J, Wu Z, Huang Y Chin Med. 2023; 18(1):112.

PMID: 37674245 PMC: 10481484. DOI: 10.1186/s13020-023-00815-8.


A comprehensive review on Schisandrin and its pharmacological features.

Wang X, Wang X, Yao H, Shen C, Geng K, Xie H Naunyn Schmiedebergs Arch Pharmacol. 2023; 397(2):783-794.

PMID: 37658213 DOI: 10.1007/s00210-023-02687-z.


Deoxyschizandrin treats mice with ulcerative colitis possibly via the TLR4/NF-κB signaling pathway.

Yu S, Qian H Am J Transl Res. 2021; 13(4):3856-3863.

PMID: 34017577 PMC: 8129281.


Protective effect of Anwulignan against D-galactose-induced hepatic injury through activating p38 MAPK-Nrf2-HO-1 pathway in mice.

Gao J, Yu Z, Jing S, Jiang W, Liu C, Yu C Clin Interv Aging. 2018; 13:1859-1869.

PMID: 30323572 PMC: 6174312. DOI: 10.2147/CIA.S173838.


Pharmacokinetics of Schizandrin and Its Pharmaceutical Products Assessed Using a Validated LC-MS/MS Method.

Li C, Cheng Y, Hsieh C, Tsai T Molecules. 2018; 23(1).

PMID: 29342955 PMC: 6017025. DOI: 10.3390/molecules23010173.